Clinical and laboratory characteristics of dengue and COVID-19 coinfected patients in Dhaka, Bangladesh
- PMID: 35443278
- PMCID: PMC9047248
- DOI: 10.1093/trstmh/trac031
Clinical and laboratory characteristics of dengue and COVID-19 coinfected patients in Dhaka, Bangladesh
Abstract
Background: Dengue-COVID-19 coinfection is one of the greatest emerging challenges in dengue-endemic areas during the continuing pandemic. With coinciding clinical and laboratory pictures, early diagnosis becomes burdensome, with management discrepancy.
Methods: A descriptive study was performed on dengue-COVID-19 coinfected patients during July-August 2021 for an overview of disease progression, severity and outcome. A total of 11 patients who were positive for dengue NS1 and/or antidengue IgM were included in this study.
Results: In total, 45.5% patients developed severe COVID-19 disease, 45.5% patients developed group B dengue fever and 9% patients developed group C dengue fever. Concurrent severity of both diseases was seen to be rare, except for in one patient.
Conclusion: Early diagnosis and compatible management still stand as basic principles to prevent fatality and morbidity.
Keywords: BSMMU; COVID-19; dengue; dengue–COVID-19 coinfection; pandemic.
© The Author(s) 2022. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.
References
-
- Hsan K, Hossain MM, Sarwar MSet al. . Unprecedented rise in dengue outbreaks in Bangladesh. Lancet Infect Dis. 2019;19:1287. - PubMed
-
- WHO . Bangladesh Coronavirus Dashboard-WHO. Available at: https://covid19.who.int/region/searo/country/bd [accessed March 4, 2021].
-
- Cousins S. Dengue rises in Bangladesh. Lancet Infect Dis. 2019;19(2):138. - PubMed
-
- Estofolete CF, Machado LF, Zini Net al. . Presentation of fatal stroke due to SARS-CoV-2 and dengue virus coinfection. J Med Virol. 2021;93(3):1770–5. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical